Replies to post #302391 on Innovation Pharmaceuticals Inc (IPIX)

[Here Today]

That would be correct.

[Here Today]

CEO Leo raised money of late via funding from a MFO which is documented in all the filings.

The company recently paid an obscenely cheap $35k for additional testing of Brilacidin by George Mason University which was announced by EurekaAlert.

[Here Today]

That additional testing of Brilacidin is in Addison to the testing being conducted at the 2 RBL’s and the PHRI which are all currently testing Brilacidin as a Covid19 Therapeutic at each location. So the company has many “Irons in the Fire” you can say..

[MinnieM]

Recent company focus has been to get Brilacidin tested against covid as a therapeutic. A vaccine had been looked at, but, that has been set aside for now.

At the moment, two US RBL's are testing Brilacidin and they intend to publish their results individually.

Speaking of publishing and/or news. This just came out and it shows Brilacidin listed as one of seven working on a therapeutic. Compare Brilacidin to the other potential therapeutics. It has already been already tested in humans in phase 2 trials.

http://www.thepmc.org/lib/corona-virus-6-01-20/

Here's the link to the 59 page pdf:
https://www.thepmc.org/new/wp-content/uploads/2020/06/Corona-virus-6-01-20.pdf

I'm not sure what to think about the grant recently applied for. This would be the fourth one received thus far regarding covid. Will it just cover additional testing, or will it also cover a clinical trial. We just don't know yet. (2 grants for first round of testing for each lab. A third grant for a 2nd round for George Mason? And, now this one.)

Whatever the case, with the global focus on covid19 I fully expect them to get a grant appoved for a clinical trial. Government or private doesn't matter. Covid presents an unusual situation. Someone will come in and make sure a trial is run if the published results are good. Yes, it is a gamble, but, all stocks are. But, there is great pressure to solve this covid issue.

You might also want to take a look at this post for a bit of history on Brilacidin: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156294660

Good luck in whatever you decide to do. Without having followed the stock the way I have, I'd likely be hesitant too with the current cash situation. ;)







I understand that, and I’m not asking somebody to tell me if I should or shouldn’t invest. I’m asking how they expect to fund the trials.

If the answer is through the “research” grant that they applied for on June 11th, then that answers my question.